Scynexis announces results from SCY-635 Phase 2a study on HCV (News Medical) - Nov 7, 2012 - "Scynexis...announced that the results of a Phase 2a study of...SCY-635...will be the subject of an oral presentation at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases..."
P2 data • Hepatitis C Virus
|